ODDB.org: Open Drug Database

Orion Pharma AG - Stalevo 125/31.25/200 mg, Filmtabletten

Swissmedic Registration	56676	Sequence	06
Product name	Stalevo 125/31.25/200 mg	Description	Filmtabletten
ATC-Classification	N04BA03	ATC-Description	Levodopa, Decarboxylase Inhibitor and Comt Inhibitor
Introduction of Sequence	12.01.2010

Composition

entacaponum 200.0 mg, levodopum 125.0 mg, carbidopum 31.25 mg ut carbidopum monohydricum, maydis amylum, mannitolum, carmellosum natricum conexum corresp. natrium 2.27 mg, povidonum, magnesii stearas, Überzug: hypromellosum, saccharum 1.62 mg, E 171, E 172 (rubrum), magnesii stearas, polysorbatum 80, glycerolum (85 per centum) pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Carbidopa	31.25 mg
Entacapone	200 mg
Levodopa	125 mg

BAG: Active Agent	Dose
Carbidopa	31.25 mg
Entacapone	200 mg
Levodopa	125 mg

Inactive agents	Dose	additional_information
(Rubrum)
Carmellosum Natricum Conexum
E 171		color.
E 172		color.
Glycerolum (85 per Centum) pro Compresso Obducto
Hypromellosum		Überzug
Magnesii Stearas
Mannitol
Maydis Amylum
Polysorbatum 80
Povidone
Saccharum	1.62 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
026	30 Tablet(s)	22.78	41.00	B	SL	Yes
027	100 Tablet(s)	70.54	92.50	B	SL	Yes

2025	©ywesee GmbH